echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Will vaccination be given priority in areas with more severe outbreaks, such as Shijiazhuang? The National Health and Health Commission responded in this way

    Will vaccination be given priority in areas with more severe outbreaks, such as Shijiazhuang? The National Health and Health Commission responded in this way

    • Last Update: 2021-01-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Zeng Yixin, deputy director of the National Health and Health Commission and head of the vaccine research and development team of the Joint Prevention and Control Mechanism of the State Council, said at a press conference of the Joint Prevention and Control Mechanism of the State Council that since December 15, China has officially carried out vaccination work for key population groups.
    In the vaccination work, we have established a relatively perfect vaccination point set-up norms, vaccination personnel training, screening of infected personnel, adverse reaction monitoring, emergency treatment, serious adverse reaction expert consultation and a series of systems to ensure the safety and smoothness of vaccination work.
    Zeng Yixin said that more than 9 million doses of vaccination, once again proved that China's new coronavirus vaccine has better safety.
    With the conditional listing of the new coronavirus vaccine, especially with the gradual improvement of production and supply support capacity, China will comprehensively and orderly promote the high-transmission population, high-risk groups and the general population vaccination work, and the implementation of free vaccination for all.
    through orderly vaccination, eligible people can achieve "catch-up", so as to build an immune barrier to block the spread of the new coronavirus in the country.
    Zeng Yixin said that from December 15 to launch the key population of the new crown vaccination process, we require all places to refer to the nucleic acid testing should be tested the model, by all levels of government to organize and arrange cost protection, to promote the new crown pneumonia vaccination.
    individual does not bear the cost of the vaccine and the cost of vaccination, that is, the cost of the vaccine and the cost of vaccination are included free of charge.
    process, we have also found that individual places have charged personal fees, we are in the State Council joint defense mechanism integrated group on behalf of the text to request immediate rectification.
    In response to adverse reactions to the new crown vaccination, Wang Huaqing, chief expert of the immunization program of the Cdc of China, said at a press conference of the Joint Prevention and Control Mechanism of the State Council on the 9th that regarding adverse vaccine reactions in China, according to the monitoring results, 80% of the suspected adverse reactions reported now are general adverse reactions, of which 6 out of 100,000 are abnormal reactions.
    most of these abnormal reactions are allergic rashes, and there are other allergic reactions, including adverse reactions such as angioedema, which are about one in a million.
    no anomalies compared to historical data.
    For the recent new coronavirus mutation on the effectiveness of the vaccine, the Deputy Director of the National Health And Wellness Commission, the State Council joint prevention and control mechanism of the scientific research team vaccine research and development team leader Zeng Yixin said that in the United Kingdom, the virus has a new mutation, is the S protein 501 amino acid mutation, because this mutation is just in the key position, is the RBD region of the S protein, this area is the virus and human cells binding to the key part, so the mutation is highly concerned.
    recently, two scientific research units have done special research, one is the Chinese Academy of Medical Sciences Institute of Experimental Animals, and the other is the Institute of Virus Research of Zhongshan University, both units have been dedicated to the study of this strain.
    They compared the viruses that appeared in China in January, February, March, April, May and June with the uk's mutant strains and found that the antibodies produced by the new coronavirus immune monkeys and immune bodies were equally positive for the early virus strains in the country and the UK's mutant strains, which they have submitted to the journal and are awaiting publication.
    results should strengthen our confidence that our vaccine has the same ability to make a change.
    at least for now, it is clear that the mutation of the virus will not affect the protection of the vaccine.
    , of course, the mutation of the virus is an ongoing process that occurs every day.
    , the new coronavirus is still in an acceptable range, the rate of variation is not particularly fast.
    But we have to pay great attention to this problem, on the one hand, we still have to continue to closely monitor the virus mutation, but also we have to do a good job of coping, in case the mutation accumulates to a certain extent, affecting the protection of our vaccine, we also need to prepare in advance, to carry out broad-spectrum new crown vaccine or mutated new crown vaccine research, in order to effectively respond to possible problems.
    A reporter asked at the scene"will be in Shijiazhuang and other areas with more serious outbreaks of priority vaccination," said Cui Gang, head of the Cdcs Bureau of the National Health And Wellness Commission, for the mutant strain vaccination, Hebei Province has been vaccinated nearly 140,000 people.
    hebei Province should speed up the progress, as soon as possible to complete the vaccination of key groups of people, and implement various prevention and control measures, the public seriously do a good job of protection.
    the Shijiazhuang outbreak, whether to adjust vaccination strategy, Hebei Province will be based on the needs of prevention and control work, vaccine characteristics and other comprehensive factors for overall consideration.
    Shi Yingchun Gu Xiaoci Source: CCTV News Client Copyright Notice: All text, images and audio and video materials that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medical, are not authorized, and may not be reproduced by any media, website or individual, and shall be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.